Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Edinburgh-based Well Cow has moved closer to commercialization after completing a trial of a new bolus sensor for monitoring dietary health in cattle.
UK aquaculture health specialist Benchmark is to commercialize the first environmentally benign purification system to help salmon producers fight sea lice.
Scientists at the UK's Pirbright Institute say they have successfully validated two new portable tests for the diagnosis of foot-and-mouth disease (FMD).
Researchers in the US have discovered calves conceived by cows experiencing heat stress are less healthy and productive during the whole of their life cycle.
Danish biosciences company Chr Hansen has further strengthened its animal health division by adding Marcelo Lang as global strategic marketing director for monogastric products.
Kyoto-based measuring device firm Ishida has developed a large-scale instrument for detecting anisakis worms in fish.
The US FDA hopes to use a biomass denominator as part of its quest for more accurate annual data concerning the level of antimicrobials sold or distributed for use in food-producing animals.
ECO Animal Health has added another authorization to its Aivlosin antibiotic portfolio, with Turkey the latest country to approve the product for use in commercial layers.
Merck Animal Health has gained US FDA approval for a respiratory and pain treatment for cattle.
The Philippines said it has discovered its first case of highly pathogenic avian influenza, according to local media.
Animal health authorities in south Australia are investing Aus$3million ($2.35 million) in a project to reduce the impact of 21 endemic sheep diseases in the region.
The WorldFish center in Malaysia has appointed a UK aquaculture specialist to be its next director general.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.